Information from Pharmaceutical Companies and the Quality, Quantity, and Cost of Physicians' Prescribing: A Systematic Review

@inproceedings{Spurling2010InformationFP,
  title={Information from Pharmaceutical Companies and the Quality, Quantity, and Cost of Physicians' Prescribing: A Systematic Review},
  author={Geoffrey K. P. Spurling and Peter R. Mansfield and Brett David Montgomery and Joel Lexchin and Jenny Doust and Noordin Othman and Agnes Isabelle Vitry},
  booktitle={PLoS medicine},
  year={2010}
}
BACKGROUND Pharmaceutical companies spent $57.5 billion on pharmaceutical promotion in the United States in 2004. The industry claims that promotion provides scientific and educational information to physicians. While some evidence indicates that promotion may adversely influence prescribing, physicians hold a wide range of views about pharmaceutical promotion. The objective of this review is to examine the relationship between exposure to information from pharmaceutical companies and the… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 115 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 87 references

The effects of detailing on prescribing decisions under two-sided learning

  • A Ching, M Ishihara
  • Available: http://mpra.ub.uni-muenchen.de/4935…
  • 2007
Highly Influential
11 Excerpts

Response modeling with nonrandom marketing-mix variables

  • P Manchanda, P Rossi, P Chintagunta
  • J Marketing Res
  • 2004
Highly Influential
9 Excerpts

Similar Papers

Loading similar papers…